Journal of Clinical Oncology

Click cover for current issue table of contents

Announcements

Now available, JCO apps for iPad® and iPhone®

- 2012 ASCO Annual Meeting Proceedings

» Early Release Articles : New articles
posted every Monday at 4 p.m. ET

» Top 50 Viewed Articles : Updated on the 20th of every month

» JCO Translations

» JCO Review Series

» JCO News Releases

» Career Center



CURRENT ISSUE: MAY 20, 2012

HIGHLIGHTS

Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study Tveit et al
Editorial: Grothey et al
Podcast: O'Connell
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes von Minckwitz et al
Editorial: Schott et al
Adjuvant Chemotherapy for Non–Small-Cell Lung Cancer in the Elderly Cuffe et al
Podcast: Langer
Phase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox (CAT-8015 or HA22) in Patients With Hairy Cell Leukemia Kreitman et al
UTP: Park et al
Podcast: Bishop
Phase II Study of Ganitumab, a Fully Human Anti–Type-1 Insulin-Like Growth Factor Receptor Antibody, in Patients With Metastatic Ewing Family Tumors or Desmoplastic Small Round Cell Tumors Tap et al
Review Article: Dissecting the Heterogeneity of Triple-Negative Breast Cancer Metzger-Filho et al
Understanding the Pathway: Targeted Immunotherapy for Hairy Cell Leukemia Park et al

Alternate international access [more info]

	Podcasts in Current Issue
The Rich Get Richer: Another Efficacious Option for Refractory Hairy Cell Leukemia By Michael R Bishop [Disclosures] Posted February 21, 2012 _{(Download file - duration 0:08:15, file size 7.58 MB)} Related Articles: Kreitman et al [Abstract]
The Use of Adjuvant Therapy in Elderly Patients with Resected Non-Small Cell Lung Cancer (NSCLC) By Corey Langer [Disclosures] Posted April 23, 2012 _{(Download file - duration 0:06:52, file size 6.32 MB)} Related Articles: Cuffe et al [Abstract]
No Advantage to Combining Cetuximab with 5FU, Leucovorin, and Oxaliplatin in Metastatic Colorectal Cancer By Michael J O'Connell [Disclosures] Posted April 2, 2012 _{(Download file - duration 0:06:43, file size 6.17 MB)} Related Articles: Tveit et al [Abstract]